Bringing It All Back Home: Reshaping Ophthalmology's Clinic with Home OCT

When a breakthrough therapy receives US Food and Drug Administration (FDA) approval, it represents years of research, clinical trials, and collaboration to bring an additional weapon to the physician’s arsenal. But as revolutionary as these treatments may be, their impact is often inseparable from the tools used to track their effects.